Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07757789 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Thrombocytopenia is common in antiphospholipid syndrome (APS) and is now included in the 2023 ACR/EULAR APS criteria as an important non criteria/hematologic feature. Persistent or low-moderate thrombocytopenia independently predicts reduced long-term survival in APS, with hazard ratios for mortality around 2.7-4.4, and is associated with a severe disease phenotype and thrombotic deaths.
Trial Details
NCT Number NCT07757789
Lead Sponsor New Valley University
Conditions
(from sponsor)		 Antiphospholipid Syndrome
Related terms Antiphospholipid Syndrome, Thrombocytopenia
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov